EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Idiopathic Hypertrophic Spinal Pachymeningitis

Ashutosh Gupta, Daniel Um, Rohan Samant, Rodrigo Hasbun, Rohini D Samudralwar, Shitiz Sriwastava, Rajesh K Gupta

Journal of Medical Cases · 2023-12 · 14 (12) · 405-412

DOI: 10.14740/jmc4149 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Medical Cases, 2023-12. Verfasst von Ashutosh Gupta und 6 weiteren Autor:innen. Beteiligte Einrichtung: McGovern Medical School, UT Health Science Center at Houston, Houston, TX 77030, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertrophic pachymeningitis (HP) is a rare presentation with duramater thickening and fibrosis which can result in cranial or spinal compressive disease. Most cases of spinal HP require surgical management. We present an uncommon case of idiopathic hypertrophic spinal pachymeningitis (IHSP) in a 40-year-old male who showed complete improvement to steroids without any further relapses. The patient presented with bilateral upper limb weakness with magnetic resonance imaging (MRI) spine showing diffuse dural thickening of the entire spine with cervical cord compression. He had an extensive workup for underlying etiology and worsening symptoms until he was diagnosed with IHSP. Later, he was started on high-dose steroids with good response and no relapse after 2 years. A descriptive analysis of IHSP cases since 2009 including ours showed that it usually occurs after 50s with female preponderance. Weakness and sensory loss are the most common complaints with 50% patients showing clinical signs of myelopathy like hyperreflexia, clonus, Babinski sign and sensory level. Cerebrospinal fluid (CSF) and inflammatory markers like erythrocytic sedimentation rate (ESR) and C-reactive protein (CRP) can be used to assess disease progression and prognosis. Surgical removal of HP followed by steroids is the best line of management while steroids alone can be tried in cases where clinical signs of myelopathy are absent.

Schlagwörter

Stichwörter der Autor:innen

Hypertrophic pachymeningitisIHSPIdiopathicSpinal cord compressionSteroids

Autor:innen und Institutionen

  • McGovern Medical School, UT Health Science Center at Houston, Houston, TX 77030, USA.
  • Department of Radiology, UT Health Science Center at Houston, TX 77030, USA.
  • Department of Infectious Disease, UT Health Science Center at Houston, TX 77030, USA.
  • Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA.
  • Division of Multiple Sclerosis and Neuroimmunology, Department of Neurology, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.

Zitieren

APA

Gupta, A., Um, D., Samant, R., Hasbun, R., Samudralwar, R. D., Sriwastava, S., & Gupta, R. K. (2023). Idiopathic Hypertrophic Spinal Pachymeningitis. Journal of Medical Cases, 14(12), 405-412. https://doi.org/10.14740/jmc4149

Vancouver

Gupta A, Um D, Samant R, Hasbun R, Samudralwar RD, Sriwastava S, et al. Idiopathic Hypertrophic Spinal Pachymeningitis. Journal of Medical Cases. 2023;14(12):405-412. doi:10.14740/jmc4149

BibTeX
@article{Gupta2023,
  author = {Gupta, Ashutosh and Um, Daniel and Samant, Rohan and Hasbun, Rodrigo and Samudralwar, Rohini D and Sriwastava, Shitiz and Gupta, Rajesh K},
  title = {Idiopathic Hypertrophic Spinal Pachymeningitis},
  journal = {Journal of Medical Cases},
  year = {2023},
  volume = {14},
  number = {12},
  pages = {405--412},
  doi = {10.14740/jmc4149}
}
Kostenlos starten →